Plasma or serum in therapeutic drug monitoring and clinical toxicology

Casarett LJ, Doull J. Toxicology. The basic science of poisons. New York: Macmillan Publishing Company, 1975.

Moffat AC, ed. Clarke's isolation and identification of drugs. 2nd ed. London: The Pharmaceutical Press, 1986.

Beermann B, Groschinsky-Grind M. Clinical pharmaco-kinetics of diuretics. Clin Pharmacokinet 1980;5:221–45.

Keown PA, Stiller CR, Stawecki M, McMichael J, Howson W. Pharmacokinetics and interactions of ciclo- sporin. In: Schindler R, ed. Ciclosporin in autoimmune diseases. Berlin: Springer-Verlag, 1985:39–42.

Uges DRA, Van der Paauw HJW. Alcohol, de bloed-proef en de contra-expertise [Alcohol, blood test and counterexpertise]. Ned Forens Tijdschr 1982;2:7–9.

Maguire KP, Burrows GD, Norman JR, Scoggings BA. Blood plasma distribution ratios of psychotropic drugs. Clin Chem 1980;26:1624–5.

Linnoila M, Dorrity F, Jobson K. Plasma and erythrocyte levels of tricyclic antidepressants in depressed patients. Am J Psychiatry 1978;135:557–61.

De Vries EGE, Greidanus J, Mulder NH, et al. A phase 1 pharmacokinetic study with 21-day continuous infusion of epirubicin. J Clin Oncol 1987;5:1445–51.

De Vries EGE, Greidanus J, Mulder NH, et al. A phase 1 and pharmacokinetic study with 21-day continuous infusion of mitoxantrone (MX). Am Soc Clin Oncol 1988;7:58.

Smits RV, Stewart JT. Textbook of biopharmaceutic analysis. Philadelphia: Lea & Febiger, 1981:3–16.

Toseland PA. Samples and sampling. In: Moffat AC, ed. Clarke's isolation and identification of drugs. 2nd ed. London: The Pharmaceutical Press, 1986:111–7.

Hichs JA, Iosefsohn M. Another physician's office analyser: the Abbott vision evaluated. Clin Chem 1987;33:817–9.

Walters MI, Roberts WH. Gentamicin/heparin interactions: effects on two immunoassays and on protein binding. Ther Drug Monitor 1984;6:199–202.

Meyers DR, DeFehr J, Bennett WM, Porter GA, Olsen GD. Gentamicin binding to serum and plasma proteins. Clin Pharmacol Ther 1978;23:356–60.

Cipolle RJ, Zaske DE, Crossley K. Gentamicin/tobramycin. Therapeutic use and serum concentration monitoring. In: Taylor WJ, Finn LA, eds. Individualizing drug therapy. 1. New York: Frank Cross Townsend Inc., 1981:138.

Dube LM, Ho-Ngoc A, Davies RF, Beaulands DS, Mousseau N, McGilveray IJ. Influence of protamine on heparine induced increases of lidocaine free fraction. Res Commun Chem Pathol Pharmacol 1983;42:401–15.

Pearce GA, Brown KF. Heat inhibition ofin vitro lipolysis and14C ibuprofen protein binding in plasma from heparinized uraemic subjects. Life Sci 1983; 33:1457–66.

Naranjo CA, Sellers EM, Khouw V, Alexander P, Fan T, Shaw J. Variability in heparin effect on serum drug binding. Clin Pharmacol Ther 1980;28:545–50.

Schulz P, Abang A, Giacomini JC, Blaschke TF, Giacomini KM. Effect of heparin on the red blood cell-to-plasma concentration ratio of diphenylhydantoin and prazosin. Ther Drug Monitor 1983;5:497–9.

Whelpton R. Tricyclic antidepressants and neuroleptics. In: Curry AS, ed. Antalytical methods in human toxicology. Part 1. Weinheim: Verlag Chemie, 1985: 139–58.

Flanagan RJ, Widdop B. Clinical toxicology. In: Curry AS, ed. Analytical methods in human toxicology. Part 1. Weinheim: Verlag Chemie, 1985:37–66.

Froentjes W, Schute JB, Strengers Th, Verwey AMA. Analytisch-chemische aspecten van de wijziging van de Wegenverkeerswet (11) [Analytical and clinical aspects of the change in the Traffic Act (11)]. Pharm Weekbl 1976;111:349–62.

Werk EE jr. Interference of heparin containing benzyl alcohol in the fluorometric determination of plasma corticosteroids. J Clin Endocrinol 1967;27:1350.

Foley B, Johnson SA, Hackley B, Smith JC jr, Halsted JA. Zinc content of human platelets. Proc Soc Exp Biol Med 1968;128:265–9.

Keyzer JJ, Oosting E, Wolthers BG, Muskiet FAJ, Hindriks FR, Van der Slik W. Zinc in plasma and serum: influence of contamination due to the collection tubes. Pharm Weekbl [Sci] 1983;5:248–51.

Carmel R. Vitamin B12-binding proteins in serum and plasma in various disorders. Effects of anticoagulants. Am J Pathol 1978;69:319–25.

Kubasik NP, Sine HE. Results for serum and plasma compared in 15 selected radioassays. Clin Chem 1978;24:137–9.

Huizinga JR, Gips CH. Evaluation of the UV-340 spectrophotometric determination for pseudocholin-esterase activity (EC 3.1.1.8) in human serum. J Clin Chem Clin Biochem 1987;25:161–5.

Smits RV, Stewart JT. Microbiologic assay methods. In: Textbook of biopharmaceutic analysis. Philadelphia: Lea & Febiger, 1981:249–59.